The HIF pathway in cancer

被引:156
作者
Maxwell, PH [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Renal Sect, London W12 0NN, England
基金
英国惠康基金;
关键词
HIF; VHL; hypoxia; cancer; angiogenesis;
D O I
10.1016/j.semcdb.2005.03.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The transcription factor hypoxia-inducible factor-1 (HIF) is commonly activated in cancer. This has major effects on gene expression, and is important in tumor angiogenesis. Besides being activated by low oxygen, genetic events in cancer contribute to activating HIF. Most striking is that loss of function of the VHL tumour suppressor protein results in constitutive activation of the HIF pathway. An important aim is to define the contribution of HIF activation to the evolution of different cancers, and its potential as a therapeutic target. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 66 条
[1]   Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor [J].
Appelhoff, RJ ;
Tian, YM ;
Raval, RR ;
Turley, H ;
Harris, AL ;
Pugh, CW ;
Ratcliffe, PJ ;
Gleadle, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :38458-38465
[2]   HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia [J].
Berra, E ;
Benizri, E ;
Ginouvès, A ;
Volmat, V ;
Roux, D ;
Pouysségur, J .
EMBO JOURNAL, 2003, 22 (16) :4082-4090
[3]   Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes [J].
Biju, MP ;
Neumann, AK ;
Bensinger, SJ ;
Johnson, RS ;
Turka, LA ;
Haase, VH .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (20) :9038-9047
[4]   Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans [J].
Bishop, T ;
Lau, KW ;
Epstein, ACR ;
Kim, SK ;
Min, J ;
O'Rourke, D ;
Pugh, CW ;
Gleadle, JM ;
Taylor, MS ;
Hodgkin, J ;
Ratcliffe, PJ .
PLOS BIOLOGY, 2004, 2 (10) :1549-1560
[5]   The hypoxic response of tumors is dependent on their microenvironment [J].
Blouw, B ;
Song, HQ ;
Tihan, T ;
Bosze, J ;
Ferrara, N ;
Gerber, HP ;
Johnson, RS ;
Bergers, G .
CANCER CELL, 2003, 4 (02) :133-146
[6]   Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex [J].
Brugarolas, J ;
Lei, K ;
Hurley, RL ;
Manning, BD ;
Reiling, JH ;
Hafen, E ;
Witter, LA ;
Ellisen, LW ;
Kaelin, WG .
GENES & DEVELOPMENT, 2004, 18 (23) :2893-2904
[7]   TSC2 regulates VEGF through mTOR-dependent and -independent pathways [J].
Brugarolas, JB ;
Vazquez, F ;
Reddy, A ;
Sellers, WR ;
Kaelin, WG .
CANCER CELL, 2003, 4 (02) :147-158
[8]   Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia [J].
Bruick, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9082-9087
[9]   Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions [J].
Cao, Y ;
Karsten, U ;
Zerban, H ;
Bannasch, P .
VIRCHOWS ARCHIV, 2000, 436 (02) :119-126
[10]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490